BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28314325)

  • 1. MIC1/GDF15 as a Bone Metastatic Disease Biomarker.
    Windrichova J; Fuchsova R; Kucera R; Topolcan O; Fiala O; Finek J; Slipkova D
    Anticancer Res; 2017 Mar; 37(3):1501-1505. PubMed ID: 28314325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
    Windrichova J; Fuchsova R; Kucera R; Topolcan O; Fiala O; Finek J; Slipkova D; Karlikova M; Svobodova J
    Anticancer Res; 2016 Apr; 36(4):1973-8. PubMed ID: 27069189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis.
    Windrichova J; Kucera R; Fuchsova R; Topolcan O; Fiala O; Svobodova J; Finek J; Slipkova D
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818807466. PubMed ID: 30343636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of TPS and TPA in the Diagnostics of Distant Metastases.
    Kucera R; Topolcan O; Fiala O; Kinkorova J; Treska V; Zedníková I; Slouka D; Simanek V; Safanda M; Babuska V
    Anticancer Res; 2016 Feb; 36(2):773-7. PubMed ID: 26851038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
    Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
    J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
    Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressiveness of Bone Markers in Breast Cancer with Bone Metastases.
    Zulauf N; Brüggmann D; Groneberg D; Oremek GM
    Oncology; 2019; 97(4):236-244. PubMed ID: 31412345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activin A circulating levels in patients with bone metastasis from breast or prostate cancer.
    Leto G; Incorvaia L; Badalamenti G; Tumminello FM; Gebbia N; Flandina C; Crescimanno M; Rini G
    Clin Exp Metastasis; 2006; 23(2):117-22. PubMed ID: 16841234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
    Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
    J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients.
    Tokuda O; Harada Y; Ohishi Y; Matsunaga N; Edenbrandt L
    Ann Nucl Med; 2014 May; 28(4):329-39. PubMed ID: 24573796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
    Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W; Muley T; Herb KP; Schmidt-Gayk H
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.
    Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET
    Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
    Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of GDF15 in bone metastasis of lung adenocarcinoma cells.
    Duan L; Pang HL; Chen WJ; Shen WW; Cao PP; Wang SM; Liu LL; Zhang HL
    Oncol Rep; 2019 Apr; 41(4):2379-2388. PubMed ID: 30816507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metabolic markers in bone metastases.
    Koizumi M; Yamada Y; Takiguchi T; Nomura E; Furukawa M; Kitahara T; Yamashita T; Maeda H; Takahashi S; Aiba K
    J Cancer Res Clin Oncol; 1995; 121(9-10):542-8. PubMed ID: 7559734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer.
    Zhao FL; Hu GD; Wang XF; Zhang XH; Zhang YK; Yu ZS
    J Int Med Res; 2012; 40(3):859-66. PubMed ID: 22906258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
    Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
    Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
    Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
    Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.